Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 17;21(16):5900.
doi: 10.3390/ijms21165900.

Hexobarbital Sleep Test for Predicting the Susceptibility or Resistance to Experimental Posttraumatic Stress Disorder

Affiliations

Hexobarbital Sleep Test for Predicting the Susceptibility or Resistance to Experimental Posttraumatic Stress Disorder

Maria Komelkova et al. Int J Mol Sci. .

Abstract

Hexobarbital sleep test (HST) was performed in male Wistar rats (hexobarbital 60 mg/kg, i.p.) 30 days prior to stress exposure. Based on the duration of hexobarbital-induced sleep, rats were divided into two groups, animals with high intensity (fast metabolizers (FM), sleep duration <15 min) or low intensity of hexobarbital metabolism (slow metabolizers (SM), sleep duration ≥15 min). The SM and FM groups were then divided into two subgroups: unstressed and stressed groups. The stressed subgroups were exposed to predator scent stress for 10 days followed by 15 days of rest. SM and FM rats from the unstressed group exhibited different behavioral and endocrinological patterns. SM showed greater anxiety and higher corticosterone levels. In stressed animals, anxiety-like posttraumatic stress disorder (PTSD) behavior was aggravated only in SM. Corticosterone levels in the stressed FM, PTSD-resistant rats, were lower than in unstressed SM. Thus, HST was able to predict the susceptibility or resistance to experimental PTSD, which was consistent with the changes in glucocorticoid metabolism.

Keywords: corticosterone; glucocorticoid metabolism; hexobarbital sleep test; posttraumatic stress disorder; resilience.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Key pathways of glucocorticoid tissue metabolism of in fast (FM) and slow (SM) metabolizers.
Figure 2
Figure 2
Experimental design. EPM—elevated plus maze test.
Figure 3
Figure 3
Chromatogram of rat blood plasma extract: the black line refers to absorption at 240 nm, the red line is absorption at 260 nm; N12—11-dehydrocorticosterone; N14—corticosterone.

Similar articles

Cited by

References

    1. Pitman R.K., Rasmusson A.M., Koenen K.C., Shin L.M., Orr S.P., Gilbertson M.W., Milad M.R., Liberzon I. Biological studies of post-traumatic stress disorder. Nat. Rev. Neurosci. 2012;13:769–787. doi: 10.1038/nrn3339. - DOI - PMC - PubMed
    1. Yehuda R., Seckl J. Minireview: Stress-related psychiatric disorders with low cortisol levels: A metabolic hypothesis. Endocrinology. 2011;152:4496–4503. doi: 10.1210/en.2011-1218. - DOI - PubMed
    1. Kessler R.C., Sonnega A., Bromet E., Hughes M., Nelson C.B. Posttraumatic stress disorder in the National Comorbidity Survey. Arch. Gen. Psychiatry. 1995;52:1048–1060. doi: 10.1001/archpsyc.1995.03950240066012. - DOI - PubMed
    1. Tseilikman O.B., Kozochkin D.A., Manukhina E.B., Downey H.F., Misharina M.E., Komelkova M.V., Nikitina A.A., Golodnii S.V., Dodohova M.A., Tseilikman V.E. Predicting anxiety responses to halogenated glucocorticoid drugs using the hexobarbital sleep time test. Stress. 2016;19:390–394. doi: 10.1080/10253890.2016.1183118. - DOI - PubMed
    1. Wilson A.M., McFarlane L.C., Lipworth B.J. Effects of low and high doses of inhaled flunisolide and triamcinolone acetonide on basal and dynamic measures of adrenocortical activity in healthy volunteers. J. Clin. Endocrinol. Metab. 1998;83:922–925. doi: 10.1210/jcem.83.3.4637. - DOI - PubMed